Assessment of qSOFA in the Latin America Sepsis Institute Database
1 other identifier
observational
8,435
0 countries
N/A
Brief Summary
Recently, the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) have published new definitions of sepsis, known as Sepsis 3, based on a fairly robust analysis of large, essentially American, databases. In addition to the new definition, a new screening score was suggested, named quickSOFA (qSOFA). This score is positive if two of three variables are present: respiratory rate higher than 22 ipm, reduced level of consciousness and systolic blood pressure lower than 100 mmHg. Although the receiver operator characteristics (ROC) curves suggest an adequate predictive validity for the new score, a lot of controversy around its sensitivity as a screening tool mainly in settings with high mortality rates. Current national Brazilian data show that sepsis mortality in our country, especially in public hospitals from the Unified Health System (SUS), is very high and well above world mortality. The impact of using the qSOFA in these settings is not known. In this context, the present study aims to evaluate the potential impact of using qSOFA as a screening tool in Brazilian private and public institutions. The hypothesis is that the use of qSOFA as a screening tool will have a low sensitivity. As a consequence, patients with the diagnosis of sepsis, with organ dysfunction, will not be detected by this tool. The hypothesis was also that those patients with a qSOFA negative will have a high mortality rate, mainly in Brazilian public hospitals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 15, 2017
CompletedFirst Posted
Study publicly available on registry
May 18, 2017
CompletedMay 23, 2017
May 1, 2017
10 months
May 15, 2017
May 22, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital mortality
mortality at hospital
From date of inclusion through study completion, assessed up to 100 months
Secondary Outcomes (2)
admission to ICU in the first 24 hours of the diagnosis of sepsis
From date of inclusion until 24 hours after the diagnosis of sepsis, assessed up to 24 hours after the diagnosis of sepsis
length of ICU stay of more than 48 hours
From date of inclusion until 2 days after ICU admission
Eligibility Criteria
Patients with sepsis and sepsis shock, defined by the presence of any organ dyfunctionn
You may qualify if:
- Suspected source of infection
- Presence of any of the following organ dysfunction
- Systolic blood pressure \<90 mmHg or mean arterial pressure \<65 mmHg or fall in systolic blood pressure\> 40 mmHg.
- Creatinine\> 2.0 mg / dl or diuresis less than 0.5 ml/kg/h in the last 2 hours OR
- Bilirubin\> 2mg/dl,
- Platelet count\<100,000,
- Lactate\> 2 mmol/dl (or above the reference value),
- Coagulopathy (RNI\> 1.5 or APTT\>60 sec),
- PaO2/FiO2 ratio \<300 or recent or increased O2 need to maintain SpO2\> 90
You may not qualify if:
- End of life care
- Previous sepsis episode in the same hospital admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Federal University of São Paulolead
- Latin America Sepsis Institutecollaborator
Related Publications (1)
Machado FR, Cavalcanti AB, Monteiro MB, Sousa JL, Bossa A, Bafi AT, Dal-Pizzol F, Freitas FGR, Lisboa T, Westphal GA, Japiassu AM, Azevedo LCP; Instituto Latino-Americano de Sepsis network investigators. Predictive Accuracy of the Quick Sepsis-related Organ Failure Assessment Score in Brazil. A Prospective Multicenter Study. Am J Respir Crit Care Med. 2020 Apr 1;201(7):789-798. doi: 10.1164/rccm.201905-0917OC.
PMID: 31910037DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Flavia R Machado, MD
Federal University of São Paulo
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 15, 2017
First Posted
May 18, 2017
Study Start
May 1, 2016
Primary Completion
March 1, 2017
Study Completion
April 1, 2017
Last Updated
May 23, 2017
Record last verified: 2017-05